Journal for ImmunoTherapy of Cancer (Nov 2021)

233 Human PD-L2 triggers a unique T cell inhibitory program through PD-1 engagement distinct from that of PD-L1

  • Michael Curran,
  • Chao-Hsien Chen,
  • Qinying Liu,
  • Kimal Rajapakshe,
  • Cristian Coarfa,
  • Anupallavi Srinivasamani,
  • Shwetha Hegde

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.233
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.